News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Clancy Paul J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 379 shares
@ $57.77, valued at
$21.9k
|
|
| 07/05/2023 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 380 shares
@ $62.25, valued at
$23.7k
|
|
| 06/16/2023 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 2,505 shares
@ $0
Granted 11,294 options to buy
@ $61.44, valued at
$693.9k
|
|
| 06/12/2023 |
4
| Clancy Paul J (Director) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 3,599 shares
@ $0 |
|
| 04/04/2023 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 318 shares
@ $72.27, valued at
$23k
|
|
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 339 shares
@ $66.64, valued at
$22.6k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Clancy Paul J (Director) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 13,200 options to buy
@ $2.28, valued at
$30.1k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 326 shares
@ $79.42, valued at
$25.9k
|
|
| 01/04/2022 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 343 shares
@ $73.4, valued at
$25.2k
|
|
| 10/26/2021 |
4
| Clancy Paul J (Director) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 44,033 options to buy
@ $5.51, valued at
$242.6k
Granted 65,528 options to buy
@ $5.89, valued at
$386k
|
|
| 10/21/2021 |
3
| Clancy Paul J (Director) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/04/2021 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 321 shares
@ $68.78, valued at
$22.1k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Clancy Paul J (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 8,096 options to buy
@ $53.35, valued at
$431.9k
Granted 1,686 restricted stock units
@ $0
Exercised 1,878 restricted stock units
@ $0 |
|
| 05/28/2020 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,282 shares
@ $0
Granted 10,514 options to buy
@ $98.68, valued at
$1M
|
|
| 04/02/2020 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 287 shares
@ $73.23, valued at
$21k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|